Tangerine - 36987-1377-2 - (Tangerine)

Alphabetical Index


Drug Information of Tangerine

Product NDC: 36987-1377
Proprietary Name: Tangerine
Non Proprietary Name: Tangerine
Active Ingredient(s): .1    g/mL & nbsp;   Tangerine
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Tangerine

Product NDC: 36987-1377
Labeler Name: Nelco Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102192
Marketing Category: BLA
Start Marketing Date: 19720829

Package Information of Tangerine

Package NDC: 36987-1377-2
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (36987-1377-2)

NDC Information of Tangerine

NDC Code 36987-1377-2
Proprietary Name Tangerine
Package Description 10 mL in 1 VIAL, MULTI-DOSE (36987-1377-2)
Product NDC 36987-1377
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Tangerine
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19720829
Marketing Category Name BLA
Labeler Name Nelco Laboratories, Inc.
Substance Name TANGERINE
Strength Number .1
Strength Unit g/mL
Pharmaceutical Classes Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Dietary Proteins [Chemical/Ingredient],Fruit Proteins [Chemical/Ingredient]

Complete Information of Tangerine


General Information